(Q43662467)

25 November 2017

Uncompetitive NMDA receptor antagonists potentiate morphine antinociception recorded from the tail but not from the hind paw in rats (English)

1 reference

25 November 2017

1 reference

3

Popik P

1 reference

25 November 2017

2

Danysz W

1 reference

25 November 2017

Kozela E

1

1 reference

PubMed ID

11438302

25 November 2017

language of work or name

English

0 references

publication date

1 June 2001

1 reference

European Journal of Pharmacology

25 November 2017

1 reference

25 November 2017

423

1 reference

25 November 2017

1

1 reference

25 November 2017

17-26

1 reference

Potentiation of morphine-induced antinociception in acute spinal rats by the NMDA antagonist dextrorphan

25 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901084-6

Treatment of Impaired Cerebral Function in Psychogeriatric Patients with Memantine - Results of a Phase II Double-Blind Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901084-6

New hot plate tests to quantify antinociceptive and narcotic antagonist activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901084-6

Antagonist properties of eliprodil and other NMDA receptor antagonists at rat NR1A/NR2A and NR1A/NR2B receptors expressed in Xenopus oocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901084-6

Low-dose subcutaneous ketamine infusion and morphine tolerance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901084-6

Prolongation of morphine analgesia by competitive NMDA receptor antagonist D-CPPene (SDZ EAA 494) in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901084-6

Evidence for opiate-activated NMDA processes masking opiate analgesia in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901084-6

Binding of dimemorfan to sigma-1 receptor and its anticonvulsant and locomotor effects in mice, compared with dextromethorphan and dextrorphan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901084-6

Dextromethorphan and dextrorphan in rats: common antitussives--different behavioural profiles.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901084-6

N-methyl-D-aspartate receptor antagonists potentiate morphine's antinociceptive effect in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901084-6

A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901084-6

Dextromethorphan potentiates morphine antinociception, but does not reverse tolerance in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901084-6

The NMDA receptor: central role in pain inhibition in rat periaqueductal gray

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901084-6

Spinal monoamine and opiate systems partly mediate the antinociceptive effects produced by glutamate at brainstem sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901084-6

Comparison of antinociceptive action of morphine in the periaqueductal gray, medial and paramedial medulla in rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901084-6

MorphiDex (MS:DM) double-blind, multiple-dose studies in chronic pain patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901084-6

The specific N-methyl-D-aspartate (NMDA) receptor antagonist MK-801 blocks U-50,488, but not morphine antinociception

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901084-6

Acute tolerance associated with a single opiate administration: involvement of N-methyl-D-aspartate-dependent pain facilitatory systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901084-6

Effect of the NMDA-antagonist, MK 801, on benzodiazepine-opioid interactions at the spinal and supraspinal level in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901084-6

Oral administration of dextromethorphan prevents the development of morphine tolerance and dependence in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901084-6

Excitatory amino acid antagonists (kynurenic acid and MK-801) attenuate the development of morphine tolerance in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901084-6

Glutamate in CNS disorders as a target for drug development: an update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901084-6

Amino-alkyl-cyclohexanes are novel uncompetitive NMDA receptor antagonists with strong voltage-dependency and fast blocking kinetics: in vitro and in vivo characterization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901084-6

Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist--a review of preclinical data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901084-6

Genetic differences in the antinociceptive effect of morphine and its potentiation by dextromethorphan in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901084-6

Regional variations in the pharmacology of NMDA receptor channel blockers: implications for therapeutic potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901084-6

Analgesia produced by microinjection ofl-glutamate into the rostral ventromedial bulbar nuclei of the rat and its inhibition by intrathecal α-adrenergic blocking agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901084-6

Excitatory amino acid antagonists in the rostral ventromedial medulla inhibit mesencephalic morphine analgesia in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901084-6

Dextromethorphan and neuromodulation: old drug coughs up new activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901084-6

Inhibition of Morphine Tolerance and Dependence by the NMDA Receptor Antagonist MK-801

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901084-6

The NMDA receptor antagonist MK-801 increases morphine catalepsy and lethality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901084-6

Does the noncompetitive NMDA receptor antagonist dizocilpine (MK801) really block behavioural sensitization associated with repeated drug administration?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901084-6

[3H]MK-801 labels a site on the N-methyl-D-aspartate receptor channel complex in rat brain membranes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901084-6

Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at mu-opioid receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901084-6

Acute tolerance in morphine analgesia: continuous infusion and single injection in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901084-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-2999(01)01084-6

1 reference

25 November 2017

1 reference

PubMed ID

11438302